{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:51:54Z","timestamp":1781974314827,"version":"3.54.5"},"reference-count":81,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Fragment-based drug discovery (FBDD) has emerged as a transformative strategy in\nmodern medicinal chemistry, offering a rational and efficient alternative to traditional highthroughput\nscreening (HTS). By utilizing small, low-molecular-weight fragments with moderate\nbinding affinity, FBDD enables systematic optimization into potent lead compounds with improved\nphysicochemical properties. Its modular and ligand-centric nature has proven particularly advantageous\nin accelerating early-stage drug discovery. The COVID-19 pandemic highlighted the adaptability\nof FBDD, as fragment screening and computational modeling rapidly identified inhibitors of\nthe SARS-CoV-2 main protease (M&lt;sup&gt;pro&lt;\/sup&gt;). Integration with artificial intelligence (AI) and cloud-based\nplatforms further enhanced the speed and global accessibility of fragment campaigns, setting a precedent\nfor collaborative, open-science initiatives. Beyond infectious diseases, FBDD has demonstrated\nsignificant promise in oncology, antibacterial therapy, and neurodegenerative disorders, reflecting\nits versatility across diverse therapeutic landscapes. Recent technological advances have expanded\nthe scope of FBDD. High-resolution cryo-electron microscopy and AI-driven structural prediction\nnow enable the exploration of previously inaccessible or dynamic protein targets. Emerging\nmodalities, such as PROTACs and RNA-targeted therapeutics, also intersect with fragment-based\nstrategies, opening avenues for addressing so-called \u201cundruggable\u201d proteins. Despite persistent challenges,\nincluding the need for sensitive biophysical methods and sophisticated infrastructure, the\napproach continues to evolve. Looking ahead, the convergence of FBDD with machine learning,\nopen-access fragment libraries, and global research collaboration positions it as a scalable, adaptive\nplatform for drug discovery. As future health threats demand rapid innovation, FBDD is poised to\nremain a cornerstone of both academic and industrial research pipelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113895575417219251205111700","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T07:00:30Z","timestamp":1769410830000},"page":"497-509","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in Fragment-based Drug Design: Lessons and Innovations from the Post-COVID Drug Discovery Landscape"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3572-4748","authenticated-orcid":true,"given":"Vatan","family":"Chaudhary","sequence":"first","affiliation":[{"name":"Department of Pharmacy, IIMT University, Meerut, 250001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8868-8676","authenticated-orcid":true,"given":"Atul Pratap","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, IIMT University, Meerut, 250001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4493-6983","authenticated-orcid":true,"given":"Himanchal","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, IIMT University, Meerut, 250001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8967-4672","authenticated-orcid":true,"given":"Dhananjay","family":"Taumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, IIMT University, Meerut, 250001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2301758","DOI":"10.1080\/14756366.2024.2301758","volume":"39","author":"Bibars R.S.","year":"2024","unstructured":"Bibars R.S.; Al-Balas Q.A.; Computational fragment-based drug design of potential Glo-I inhibitors. J Enzyme Inhib Med Chem  2024,39(1),2301758","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.3390\/molecules24234309","volume":"24","author":"Kirsch P.","year":"2019","unstructured":"Kirsch P.; Hartman A.M.; Hirsch A.K.H.; Empting M.; Concepts and core principles of fragment-based drug design. Molecules  2019,24(23),4309","journal-title":"Molecules"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1021\/acs.jcim.3c00209","volume":"63","author":"Bryan D.R.","year":"2023","unstructured":"Bryan D.R.; Kulp J.L.; Mahapatra M.K.; Bryan R.L.; Viswanathan U.; Carlisle M.N.; BMaps: A web application for fragment-based drug design and compound binding evaluation. J Chem Inf Model  2023,63(14),4229-4236","journal-title":"J Chem Inf Model"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/17460441.2023.2234285","volume":"18","author":"Grenier D.","year":"2023","unstructured":"Grenier D.; Audebert S.; Preto J.; Guichou J.F.; Krimm I.; Linkers in fragment-based drug design: An overview of the literature. Expert Opin Drug Discov  2023,18(9),987-1009","journal-title":"Expert Opin Drug Discov"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e202308692","DOI":"10.1002\/anie.202308692","volume":"62","author":"Stadler G.R.","year":"2023","unstructured":"Stadler G.R.; Segawa T.F.; B\u00fctikofer M.; Decker V.; Loss S.; Czarniecki B.; Torres F.; Riek R.; Fragment screening and fast micromolar detection on a benchtop NMR spectrometer boosted by photoinduced hyperpolarization. Angew Chem Int Ed  2023,62(40),e202308692","journal-title":"Angew Chem Int Ed"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/biophysica3020024","volume":"3","author":"Ivanov N.","year":"2023","unstructured":"Ivanov N.; Shulga D.; Palyulin V.A.; Decomposition of small molecules for fragment-based drug design. Biophysica  2023,3(2),362-372","journal-title":"Biophysica"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"115713","DOI":"10.1016\/j.ejmech.2023.115713","volume":"260","author":"Bhattacharya D.","year":"2023","unstructured":"Bhattacharya D.; Shi Ming Li; A.; Paul, B.; Ghosh Dastidar, U.; Santhakumar, V.; Sarkar, D.; Chau, I.; Li, F.; Ghosh, T.; Vedadi, M.; Talukdar, A. Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach. Eur J Med Chem  2023,260,115713","journal-title":"Eur J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"e202303202","DOI":"10.1002\/anie.202303202","volume":"62","author":"Cerofolini L.","year":"2023","unstructured":"Cerofolini L.; Vasa K.; Bianconi E.; Salobehaj M.; Cappelli G.; Bonciani A.; Licciardi G.; P\u00e9rez-R\u00e0fols A.; Padilla-Cort\u00e9s L.; Antonacci S.; Rizzo D.; Ravera E.; Viglianisi C.; Calderone V.; Parigi G.; Luchinat C.; Macchiarulo A.; Menichetti S.; Fragai M.; Combining solid-state NMR with structural and biophysical techniques to design challenging protein-drug conjugates. Angew Chem Int Ed Engl  2023,62(31),e202303202","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/10494820.2020.1813180","volume":"31","author":"Adedoyin O.B.","year":"2023","unstructured":"Adedoyin O.B.; Soykan E.; Covid-19 pandemic and online learning: The challenges and opportunities. Interact Learn Environ  2023,31(2),863-875","journal-title":"Interact Learn Environ"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fmolb.2020.00180","volume":"7","author":"Li Q.","year":"2020","unstructured":"Li Q.; Application of fragment-based drug discovery to versatile targets. Front Mol Biosci  2020,7,180","journal-title":"Front Mol Biosci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1039\/D2DD00061J","volume":"2","author":"Leins D.A.","year":"2023","unstructured":"Leins D.A.; Haase S.B.; Eslami M.; Schrier J.; Freeman J.T.; Collaborative methods to enhance reproducibility and accelerate discovery. Digit Discov  2023,2(1),12-27","journal-title":"Digit Discov"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/pharmaceutics16010037","volume":"16","author":"Michiba K.","year":"2023","unstructured":"Michiba K.; Watanabe K.; Imaoka T.; Nakai D.; Recent advances in the gastrointestinal complex in vitro model for ADME studies. Pharmaceutics  2023,16(1),37","journal-title":"Pharmaceutics"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"100870","DOI":"10.1016\/j.imu.2022.100870","volume":"29","author":"Alzain A.A.","year":"2022","unstructured":"Alzain A.A.; Elbadwi F.A.; Alsamani F.O.; Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies. Inform Med Unlocked  2022,29,100870","journal-title":"Inform Med Unlocked"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s42761-023-00218-w","volume":"4","author":"Simmons J.M.","year":"2023","unstructured":"Simmons J.M.; Breeden A.; Ferrer R.A.; Gillman A.S.; Moore H.; Green P.; Pariyadath V.; Quinlan E.B.; Vicentic A.; Affective science research: Perspectives and priorities from the national institutes of health. Affect Sci  2023,4(3),600-607","journal-title":"Affect Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.3390\/molecules28041777","volume":"28","author":"Dekker T.","year":"2023","unstructured":"Dekker T.; Harteveld J.W.; W\u00e1gner G.; de Vries M.C.M.; Custers H.; van de Stolpe A.C.; de Esch I.J.P.; Wijtmans M.; Green drug discovery: Novel fragment space from the biomass-derived molecule dihydrolevoglucosenone (CyreneTM). Molecules  2023,28(4),1777","journal-title":"Molecules"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/ph15111415","volume":"15","author":"Mallakuntla M.K.","year":"2022","unstructured":"Mallakuntla M.K.; Togre N.S.; Santos D.B.; Tiwari S.; Implications of fragment-based drug discovery in tuberculosis and HIV. Pharmaceuticals  2022,15(11),1415","journal-title":"Pharmaceuticals"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.tips.2023.08.014","volume":"44","author":"Csorba N.","year":"2023","unstructured":"Csorba N.; \u00c1br\u00e1nyi-Balogh P.; Keser\u0171 G.M.; Covalent fragment approaches targeting non-cysteine residues. Trends Pharmacol Sci  [Nov2023,44(11),802-816","journal-title":"Trends Pharmacol Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1021\/acs.biochem.2c00649","volume":"62","author":"Okwei E.","year":"2023","unstructured":"Okwei E.; Smith S.T.; Bender B.J.; Allison B.; Ganguly S.; Geanes A.; Zhang X.; Ledwitch K.; Meiler J.; Rosetta\u2019s predictive ability for low-affinity ligand binding in fragment-based drug discovery. Biochemistry  2023,62(3),700-709","journal-title":"Biochemistry"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1002\/1878-0261.13277","volume":"16","author":"Bon M.","year":"2022","unstructured":"Bon M.; Bilsland A.; Bower J.; McAulay K.; Fragment\u2010based drug discovery\u2014the importance of high\u2010quality molecule libraries. Mol Oncol  2022,16(21),3761-3777","journal-title":"Mol Oncol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"e2212931120","DOI":"10.1073\/pnas.2212931120","volume":"120","author":"Gahbauer S.","year":"2023","unstructured":"Gahbauer S.; Correy G.J.; Schuller M.; Ferla M.P.; Doruk Y.U.; Rachman M.; Wu T.; Diolaiti M.; Wang S.; Neitz R.J.; Fearon D.; Radchenko D.S.; Moroz Y.S.; Irwin J.J.; Renslo A.R.; Taylor J.C.; Gestwicki J.E.; von Delft F.; Ashworth A.; Ahel I.; Shoichet B.K.; Fraser J.S.; Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc Natl Acad Sci USA  2023,120(2),e2212931120","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"8288","DOI":"10.1039\/D3SC01171B","volume":"14","author":"Salvini C.L.A.","year":"2023","unstructured":"Salvini C.L.A.; Darlot B.; Davison J.; Martin M.P.; Fragment expansion with NUDELs \u2013 poised DNA-encoded libraries. Chem Sci  2023,14(7),8288-8294","journal-title":"Chem Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1039\/C9SC05586J","volume":"11","author":"Morrison C.N.","year":"2020","unstructured":"Morrison C.N.; Prosser K.E.; Stokes R.W.; Cordes A.; Metzler-Nolte N.; Cohen S.M.; Expanding medicinal chemistry into 3D space: Metallofragments as 3D scaffolds for fragment-based drug discovery. Chem Sci  2020,11(5),1216-1225","journal-title":"Chem Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.slasd.2023.09.001","volume":"29","author":"FitzGerald E.A.","year":"2024","unstructured":"FitzGerald E.A.; Vagrys D.; Opassi G.; Klein H.F.; Hamilton D.J.; Talibov V.O.; Abramsson M.; Moberg A.; Lindgren M.T.; Holmgren C.; Davis B.; O\u2019Brien P.; Wijtmans M.; Hubbard R.E.; de Esch I.J.P.; Danielson U.H.; Multiplexed experimental strategies for fragment library screening against challenging drug targets using SPR biosensors. SLAS Discov  2024,29(1),40-51","journal-title":"SLAS Discov"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"857000","DOI":"10.3389\/fmolb.2022.857000","volume":"9","author":"Arif S.M.","year":"2022","unstructured":"Arif S.M.; Floto R.A.; Blundell T.L.; Using structure-guided fragment-based drug discovery to target Pseudomonas aeruginosa infections in cystic fibrosis. Front Mol Biosci  2022,9,857000","journal-title":"Front Mol Biosci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3390\/molecules27061985","volume":"27","author":"Shulga D.A.","year":"2022","unstructured":"Shulga D.A.; Ivanov N.N.; Palyulin V.A.; In silico structure-based approach for group efficiency estimation in fragment-based drug design using evaluation of fragment contributions. Molecules  2022,27(6),1985","journal-title":"Molecules"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1039\/C5OB02461G","volume":"14","author":"Palmer N.","year":"2016","unstructured":"Palmer N.; Peakman T.M.; Norton D.; Rees D.C.; Design and synthesis of dihydroisoquinolones for fragment-based drug discovery (FBDD). Org Biomol Chem  2016,14(5),1599-1610","journal-title":"Org Biomol Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/prot.26260","volume":"90","author":"Luan B.","year":"2022","unstructured":"Luan B.; Huynh T.; Crystal-structures-guided design of fragment-based drugs for inhibiting the main protease of SARS-CoV-2. Proteins  2022,90(5),1081-1089","journal-title":"Proteins"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e280223214111","DOI":"10.2174\/1871526523666230228103845","volume":"23","author":"Ashique S.","year":"2023","unstructured":"Ashique S.; Chaudhary V.; Pal S.; Panwar J.; Kumar M.; Pramanik S.; Sinha A.; Mukherjee A.; Marburg virus- A threat during SARS-CoV-2 era: A review. Infect Disord Drug Targets  2023,23(5),e280223214111","journal-title":"Infect Disord Drug Targets"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11030-023-10601-1","volume":"28","author":"Nguyen T.H.","year":"2024","unstructured":"Nguyen T.H.; Thai Q.M.; Pham M.Q.; Minh P.T.H.; Phung H.T.T.; Machine learning combines atomistic simulations to predict SARS-CoV-2 Mpro inhibitors from natural compounds. Mol Divers  2024,28(2),553-561","journal-title":"Mol Divers"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"16637","DOI":"10.3390\/ijms242316637","volume":"24","author":"Das D.","year":"2023","unstructured":"Das D.; Duncton M.A.J.; Georgiadis T.M.; Pellicena P.; Clark J.; Sobol R.W.; Georgiadis M.M.; King-Underwood J.; Jobes D.V.; Chang C.; Gao Y.; Deacon A.M.; Wilson D.M.; A new drug discovery platform: Application to DNA polymerase eta and apurinic\/apyrimidinic endonuclease 1. Int J Mol Sci  2023,24(23),16637","journal-title":"Int J Mol Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/s41467-023-37071-1","volume":"14","author":"Cui M.","year":"2023","unstructured":"Cui M.; Nguyen D.; Gaillez M.P.; Heiden S.; Lin W.; Thompson M.; Reddavide F.V.; Chen Q.; Zhang Y.; Trio-pharmacophore DNA-encoded chemical library for simultaneous selection of fragments and linkers. Nat Commun  2023,14(1),1481","journal-title":"Nat Commun"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"e2310933120","DOI":"10.1073\/pnas.2310933120","volume":"120","author":"Jiang W.","year":"2023","unstructured":"Jiang W.; Wijerathne T.D.; Zhang H.; Lin Y.C.; Jo S.; Im W.; Lacroix J.J.; Luo Y.L.; Structural and thermodynamic framework for PIEZO1 modulation by small molecules. Proc Natl Acad Sci USA  2023,120(50),e2310933120","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.3390\/ijms24098083","volume":"24","author":"Andrianov A.M.","year":"2023","unstructured":"Andrianov A.M.; Shuldau M.A.; Furs K.V.; Yushkevich A.M.; Tuzikov A.V.; AI-driven de novo design and molecular modeling for discovery of small-molecule compounds as potential drug candidates targeting SARS-CoV-2 main protease. Int J Mol Sci  2023,24(9),8083","journal-title":"Int J Mol Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/children10020246","volume":"10","author":"Lubrano R.","year":"2023","unstructured":"Lubrano R.; Martucci V.; Marcellino A.; Sanseviero M.; Sinceri A.; Testa A.; Frasacco B.; Gizzone P.; Del Giudice E.; Ventriglia F.; Bloise S.; Emergency department admissions of children with chest pain before and during COVID-19 pandemic. Children  2023,10(2),246","journal-title":"Children"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/pon.6030","volume":"32","author":"Thaduri A.","year":"2023","unstructured":"Thaduri A.; Garg P.K.; Malhotra M.; Singh M.P.; Poonia D.R.; Priya M.; Tyagi A.; Kumar A.; Bhardwaj A.; Jat B.; Panuganti A.; Majumdar K.; Usmani S.; Singh V.; Financial toxicity and mental well-being of the oral cancer survivors residing in a developing country in the era of COVID 19 pandemic - A cross-sectional study. Psychooncology  2023,32(1),58-67","journal-title":"Psychooncology"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.isprsjprs.2023.05.024","volume":"202","author":"Lv X.","year":"2023","unstructured":"Lv X.; Persello C.; Zhao W.; Huang X.; Hu Z.; Ming D.; Stein A.; Pruning for image segmentation: Improving computational efficiency for large-scale remote sensing applications. ISPRS J Photogramm Remote Sens  2023,202,13-29","journal-title":"ISPRS J Photogramm Remote Sens"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1109\/COMPSAC57700.2023.00237","author":"Varriano G.","year":"2023","unstructured":"Varriano G.; Sorgente V.; Mercaldo F.; Santone A.; Brunese L.; Computational cost of CT Radiomics workflow: A case study on COVID-19. IEEE 47th Annual Computers, Software, and Applications Conference (COMPSAC), Torino, Italy, 26-30 June  2023,1539-1544","journal-title":"IEEE 47th Annual Computers, Software, and Applications Conference (COMPSAC), Torino, Italy, 26-30 June"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e0287821","DOI":"10.1371\/journal.pone.0287821","volume":"18","author":"Ebben R.H.A.","year":"2023","unstructured":"Ebben R.H.A.; Woensdregt T.; Wielenga-Meijer E.; Pelgrim T.; de Lange A.; Berben S.A.A.; Vloet L.C.M.; The impact of COVID-19 on the mental health and well-being of ambulance care professionals: A rapid review. PLoS One  2023,18(7),e0287821","journal-title":"PLoS One"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.30574\/wjarr.2024.21.1.0347","volume":"21","author":"S. Onwusinkwue","year":"2024","unstructured":"S. Onwusinkwue; Femi Osasona; Ahmad Hamdan, Artificial intelligence (AI) in renewable energy: A review of predictive maintenance and energy optimization. World J Adv Res Rev  2024,21(1),2487-2799","journal-title":"World J Adv Res Rev"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41390-022-02226-1","volume":"93","author":"Ramgopal S.","year":"2023","unstructured":"Ramgopal S.; Sanchez-Pinto L.N.; Horvat C.M.; Carroll M.S.; Luo Y.; Florin T.A.; Artificial intelligence-based clinical decision support in pediatrics. Pediatr Res  2023,93(2),334-341","journal-title":"Pediatr Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1021\/acs.cgd.3c00411","volume":"23","author":"Tian W.","year":"2023","unstructured":"Tian W.; Li W.; Yang H.; Protein nucleation and crystallization process with process analytical technologies in a batch crystallizer. Cryst Growth Des  2023,23(7),5181-5193","journal-title":"Cryst Growth Des"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/buildings13020442","volume":"13","author":"B\u00fchler M.M.","year":"2023","unstructured":"B\u00fchler M.M.; N\u00fcbel K.; Jelinek T.; Riechert D.; Bauer T.; Schmid T.; Schneider M.; Data cooperatives as a catalyst for collaboration, data sharing and the digital transformation of the construction sector. Buildings  2023,13(2),442","journal-title":"Buildings"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"105901","DOI":"10.1016\/j.envsoft.2023.105901","volume":"172","author":"Coro G.","year":"2024","unstructured":"Coro G.; An Open Science oriented Bayesian interpolation model for marine parameter observations. Environ Model Softw  2024,172,105901","journal-title":"Environ Model Softw"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1107393","DOI":"10.3389\/fenvs.2023.1107393","volume":"11","author":"Basel A.M.","year":"2023","unstructured":"Basel A.M.; Nguyen K.T.; Arnaud E.; Craparo A.C.W.; The foundations of big data sharing: A CGIAR international research organization perspective. Front Environ Sci  2023,11,1107393","journal-title":"Front Environ Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"113891","DOI":"10.1016\/j.celrep.2024.113891","volume":"43","author":"Yerlici V.T.","year":"2024","unstructured":"Yerlici V.T.; Astori A.; Kejiou N.S.; Jordan C.A.; Khosraviani N.; Chan J.N.Y.; Hakem R.; Raught B.; Palazzo A.F.; Mekhail K.; SARS-CoV-2 targets ribosomal RNA biogenesis. Cell Rep  2024,43(3),113891","journal-title":"Cell Rep"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1112704","DOI":"10.3389\/fimmu.2023.1112704","volume":"14","author":"Liao Y.","year":"2023","unstructured":"Liao Y.; Wang J.; Zou J.; Liu Y.; Liu Z.; Huang Z.; Multi-omics analysis reveals genomic, clinical and immunological features of SARS-CoV-2 virus target genes in pan-cancer. Front Immunol  2023,14,1112704","journal-title":"Front Immunol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"18428","DOI":"10.1038\/s41598-021-97330-3","volume":"11","author":"Alves J.","year":"2021","unstructured":"Alves J.; Engel L.; de Vasconcelos Cabral R.; Rodrigues E.L.; de Jesus Ribeiro L.; Higa L.M.; da Costa Ferreira J\u00fanior O.; Casti\u00f1eiras T.M.P.P.; de Carvalho Leit\u00e3o I.; Tanuri A.; Goueli S.A.; Zegzouti H.; A bioluminescent and homogeneous SARS-CoV-2 spike RBD and hACE2 interaction assay for antiviral screening and monitoring patient neutralizing antibody levels. Sci Rep  2021,11(1),18428","journal-title":"Sci Rep"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/978-1-0716-3445-5_27","volume":"2715","author":"Ignatiou A.","year":"2024","unstructured":"Ignatiou A.; Mac\u00e9 K.; Redzej A.; Costa T.R.D.; Waksman G.; Orlova E.V.; Structural analysis of protein complexes by cryo-electron microscopy. Methods Mol Biol  2024,2715,431-470","journal-title":"Methods Mol Biol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jipb.13367","volume":"65","author":"Chen J.H.","year":"2023","unstructured":"Chen J.H.; Wang W.; Wang C.; Kuang T.; Shen J.R.; Zhang X.; Cryo-electron microscopy structure of the intact photosynthetic light-harvesting antenna-reaction center complex from a green sulfur bacterium. J Integr Plant Biol  2023,65(1),223-234","journal-title":"J Integr Plant Biol"},{"key":"ref=50","doi-asserted-by":"publisher","DOI":"10.1101\/2023.02.11.528064","author":"Ning J.","year":"2023","unstructured":"Ning J.; Glausier J.R.; Hsieh C.; Schmelzer T.; Cryo-FIB workflow for imaging brain tissue viain situ cryo-electron microscopy. bioRxiv  2023","journal-title":"bioRxiv"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev-pharmtox-051921-023255","volume":"63","author":"McNair D.","year":"2023","unstructured":"McNair D.; Artificial intelligence and machine learning for lead-to-candidate decision-making and beyond. Annu Rev Pharmacol Toxicol  2023,63,77-97","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1021\/acs.jcim.2c01088","volume":"63","author":"Long T.Z.","year":"2023","unstructured":"Long T.Z.; Shi S.H.; Liu S.; Lu A.P.; Liu Z.Q.; Li M.; Hou T.J.; Cao D.S.; Structural analysis and prediction of hematotoxicity using deep learning approaches. J Chem Inf Model  2023,63(1),111-125","journal-title":"J Chem Inf Model"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"11173","DOI":"10.1021\/jacs.3c00972","volume":"145","author":"Mattheisen J.M.","year":"2023","unstructured":"Mattheisen J.M.; Limberakis C.; Ruggeri R.B.; Dowling M.S.; Am Ende C.W.; Ceraudo E.; Huber T.; McClendon C.L.; Sakmar T.P.; Bioorthogonal tethering enhances drug fragment affinity for G protein-coupled receptors in live cells. J Am Chem Soc  2023,145(20),11173-11184","journal-title":"J Am Chem Soc"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1177\/02783649221077714","volume":"41","author":"Zhao Y.","year":"2022","unstructured":"Zhao Y.; Li Y.; Sentis L.; Topcu U.; Liu J.; Reactive task and motion planning for robust whole-body dynamic locomotion in constrained environments. Int J Robot Res  2022,41(8),812-847","journal-title":"Int J Robot Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"e202200455","DOI":"10.1002\/cphc.202200455","volume":"23","author":"Zapata-Acevedo C.A.","year":"2022","unstructured":"Zapata-Acevedo C.A.; Guevara-Vela J.M.; Popelier P.L.A.; Rocha-Rinza T.; Binding energy partition of promising IRAK-4 inhibitor (Zimlovisertib) for the treatment of COVID-19 pneumonia. chemphyschem  2022,23(24),e202200455","journal-title":"chemphyschem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/v15020570","volume":"15","author":"Ali Y.","year":"2023","unstructured":"Ali Y.; Imtiaz H.; Tahir M.M.; Gul F.; Saddozai U.A.K.; Ur Rehman A.; Ren Z.G.; Khattak S.; Ji X.Y.; Fragment-based approaches identified Tecovirimat-competitive novel drug candidate for targeting the F13 protein of the Monkeypox virus. Viruses  2023,15(2),570","journal-title":"Viruses"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e202200635","DOI":"10.1002\/cmdc.202200635","volume":"18","author":"Wamser R.","year":"2023","unstructured":"Wamser R.; Pach S.; Arkona C.; Baumgardt M.; Aziz U.B.A.; Hocke A.C.; Wolber G.; Rademann J.; A critical study on acylating and covalent reversible fragment inhibitors of SARS\u2010CoV\u20102 main protease targeting the S1 site with pyridine. ChemMedChem  2023,18(9),e202200635","journal-title":"ChemMedChem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"106269","DOI":"10.1016\/j.bioorg.2022.106269","volume":"131","author":"Zephyr J.","year":"2023","unstructured":"Zephyr J.; Rao D.N.; Johnson C.; Shaqra A.M.; Nalivaika E.A.; Jordan A.; Kurt Yilmaz N.; Ali A.; Schiffer C.A.; Allosteric quinoxaline-based inhibitors of the flavivirus NS2B\/NS3 protease. Bioorg Chem  2023,131,106269","journal-title":"Bioorg Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"105230","DOI":"10.1016\/j.antiviral.2021.105230","volume":"197","author":"Lan X.","year":"2022","unstructured":"Lan X.; Zhang Y.; Jia X.; Dong S.; Liu Y.; Zhang M.; Guo J.; Cao J.; Guo Y.; Xiao G.; Wang W.; Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library. Antiviral Res  2022,197,105230","journal-title":"Antiviral Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.1158\/1538-7445.AM2023-5333","volume":"83","author":"Hermann J.C.","year":"2023","unstructured":"Hermann J.C.; Everley R.; Marholz L.; Berberich M.; Abstract 5333: Combining chemoproteomics with machine learning identifies functionally active covalent fragments for hard-to-drug cancer drivers. Cancer Res  2023,83(7_suppl.),5333-5333","journal-title":"Cancer Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.chom.2023.07.001","volume":"31","author":"Maasch J.R.M.A.","year":"2023","unstructured":"Maasch J.R.M.A.; Torres M.D.T.; Melo M.C.R.; de la Fuente-Nunez C.; Molecular de-extinction of ancient antimicrobial peptides enabled by machine learning. Cell Host Microbe  2023,31(8),1260-1274.e6","journal-title":"Cell Host Microbe"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/brain\/awab465","volume":"145","author":"Ruck T.","year":"2022","unstructured":"Ruck T.; Nimmerjahn F.; Wiendl H.; L\u00fcnemann J.D.; Next-generation antibody-based therapies in neurology. Brain  2022,145(4),1229-1241","journal-title":"Brain"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1002\/jcc.27183","volume":"44","author":"Zarnecka J.M.","year":"2023","unstructured":"Zarnecka J.M.; Kaminska K.H.; FRAGMENTISE: A user\u2010friendly, cross\u2010platform tool to create and analyze comprehensive small\u2010molecule fragment databases. J Comput Chem  2023,44(26),2096-2102","journal-title":"J Comput Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41573-023-00692-8","volume":"22","author":"von Delft A.","year":"2023","unstructured":"von Delft A.; Hall M.D.; Kwong A.D.; Purcell L.A.; Saikatendu K.S.; Schmitz U.; Tallarico J.A.; Lee A.A.; Accelerating antiviral drug discovery: Lessons from COVID-19. Nat Rev Drug Discov  2023,22(7),585-603","journal-title":"Nat Rev Drug Discov"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11042-023-15270-8","author":"Pati S.K.","year":"2023","unstructured":"Pati S.K.; Gupta M.K.; Banerjee A.; Shai R.; Shivakumara P.;  Drug discovery through COVID-19 genome sequencing with siamese graph convolutional neural network  2023,1-35","journal-title":"Drug discovery through COVID-19 genome sequencing with siamese graph convolutional neural network"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1080\/07391102.2022.2112976","volume":"41","author":"Wang Z.","year":"2023","unstructured":"Wang Z.; Belecciu T.; Eaves J.; Reimers M.; Bachmann M.H.; Woldring D.; Phytochemical drug discovery for COVID-19 using high-resolution computational docking and machine learning assisted binder prediction. J Biomol Struct Dyn  2023,41(14),6643-6663","journal-title":"J Biomol Struct Dyn"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/10943420221117797","volume":"37","author":"Li Z.","year":"2023","unstructured":"Li Z.; Wu C.; Li Y.; Liu R.; Lu K.; Wang R.; Liu J.; Gong C.; Yang C.; Wang X.; Zhan C-G.; Luo H-B.; Free energy perturbation\u2013based large-scale virtual screening for effective drug discovery against COVID-19. Int J High Perform Comput Appl  2023,37(1),45-57","journal-title":"Int J High Perform Comput Appl"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1095606","DOI":"10.3389\/fneur.2022.1095606","volume":"13","author":"Tedjasukmana R.","year":"2023","unstructured":"Tedjasukmana R.; Budikayanti A.; Islamiyah W.R.; Witjaksono A.M.A.L.; Hakim M.; Sleep disturbance in post COVID-19 conditions: Prevalence and quality of life. Front Neurol  2023,13,1095606","journal-title":"Front Neurol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3390\/ph15111366","volume":"15","author":"McAulay K.","year":"2022","unstructured":"McAulay K.; Bilsland A.; Bon M.; Reactivity of covalent fragments and their role in fragment based drug discovery. Pharmaceuticals  2022,15(11),1366","journal-title":"Pharmaceuticals"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.tibs.2023.01.008","volume":"48","author":"Wang Z.Z.","year":"2023","unstructured":"Wang Z.Z.; Shi X.X.; Huang G.Y.; Hao G.F.; Yang G.F.; Fragment-based drug discovery supports drugging \u2018undruggable\u2019 protein\u2013protein interactions. Trends Biochem Sci  2023,48(6),539-552","journal-title":"Trends Biochem Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40779-023-00446-y","volume":"10","author":"Zhu K-F.","year":"2023","unstructured":"Zhu K-F.; Yuan C.; Du Y-M.; Sun K-L.; Zhang X-K.; Vogel H.; Jia X-D.; Gao Y-Z.; Zhang Q-F.; Wang D-P.; Zhang H-W.; Applications and prospects of cryo-EM in drug discovery. Mil Med Res  2023,10(1),10","journal-title":"Mil Med Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s42004-024-01109-2","volume":"7","author":"Jinsong S.","year":"2024","unstructured":"Jinsong S.; Qifeng J.; Xing C.; Hao Y.; Wang L.; Molecular fragmentation as a crucial step in the AI-based drug development pathway. Commun Chem  2024,7(1),20","journal-title":"Commun Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12859-023-05413-x","volume":"24","author":"Wu Y.","year":"2023","unstructured":"Wu Y.; Ni X.; Wang Z.; Feng W.; Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment. BMC Bioinformatics  2023,24(1),293","journal-title":"BMC Bioinformatics"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"e0288980","DOI":"10.1371\/journal.pone.0288980","volume":"18","author":"Molyneaux K.","year":"2023","unstructured":"Molyneaux K.; Laggner C.; Vincent J.; Brady-Kalnay S.; Small molecule antagonists of PTPmu identified by artificial intelligence-based computational screening block glioma cell migration and growth. PLoS One  2023,18(7),e0288980","journal-title":"PLoS One"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1021\/acs.jmedchem.3c02222","volume":"67","author":"Favaro A.","year":"2024","unstructured":"Favaro A.; Sturlese M.; A novel NMR-based protocol to screen ultralow molecular weight fragments. J Med Chem  2024,67(5),3874-3884","journal-title":"J Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"e202201282","DOI":"10.1002\/chem.202201282","volume":"28","author":"Tiemann M.","year":"2022","unstructured":"Tiemann M.; Nawrotzky E.; Schmieder P.; Wehrhan L.; Bergemann S.; Martos V.; Song W.; Arkona C.; Keller B.G.; Rademann J.; A formylglycine\u2010peptide for the site\u2010directed identification of phosphotyrosine\u2010mimetic fragments. Chemistry  2022,28(57),e202201282","journal-title":"Chemistry"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/14756366.2022.2149745","volume":"38","author":"Proj M.","year":"2023","unstructured":"Proj M.; Hrast M.; Bajc G.; Frlan R.; Meden A.; Butala M.; Gobec S.; Discovery of a fragment hit compound targeting D-Ala:D-Ala ligase of bacterial peptidoglycan biosynthesis. J Enzyme Inhib Med Chem  2023,38(1),387-397","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"115786","DOI":"10.1016\/j.ejmech.2023.115786","volume":"261","author":"Jose J.","year":"2023","unstructured":"Jose J.; Law R.H.P.; Leung E.W.W.; Wai D.C.C.; Akhlaghi H.; Chandrashekaran I.R.; Caradoc-Davies T.T.; Voskoboinik I.; Feutrill J.; Middlemiss D.; Jeevarajah D.; Bashtannyk-Puhalovich T.; Giddens A.C.; Lee T.W.; Jamieson S.M.F.; Trapani J.A.; Whisstock J.C.; Spicer J.A.; Norton R.S.; Fragment-based and structure-guided discovery of perforin inhibitors. Eur J Med Chem  2023,261,115786","journal-title":"Eur J Med Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13321-023-00738-4","volume":"15","author":"Kim H.W.","year":"2023","unstructured":"Kim H.W.; Zhang C.; Reher R.; Wang M.; Alexander K.L.; Nothias L-F.; Han Y.K.; Shin H.; Lee K.Y.; Lee K.H.; Kim M.J.; Dorrestein P.C.; Gerwick W.H.; Cottrell G.W.; DeepSAT: Learning molecular structures from nuclear magnetic resonance data. J Cheminform  2023,15(1),71","journal-title":"J Cheminform"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10858-022-00410-3","volume":"77","author":"Peng C.","year":"2023","unstructured":"Peng C.; Namanja A.T.; Munoz E.; Wu H.; Frederick T.E.; Maestre-Martinez M.; Iglesias Fernandez I.; Sun Q.; Cobas C.; Sun C.; Petros A.M.; Efficiently driving protein-based fragment screening and lead discovery using two-dimensional NMR. J Biomol NMR  2023,77(1-2),39-53","journal-title":"J Biomol NMR"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.3390\/molecules28104014","volume":"28","author":"Sincere N.I.","year":"2023","unstructured":"Sincere N.I.; Anand K.; Ashique S.; Yang J.; You C.; PROTACs: Emerging targeted protein degradation approaches for advanced druggable strategies. Molecules  2023,28(10),4014","journal-title":"Molecules"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575417219251205111700","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/249592\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575417219251205111700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:38:57Z","timestamp":1781973537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/249592\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":81,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113895575417219251205111700","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}